Fiala

Peptide library › Heart & blood

Enlicitide

Also known as Lipfendra, MK-0616

FDA-approved drugHeart & blood

First daily tablet that blocks PCSK9 to lower LDL ("bad") cholesterol, a job that previously needed injections.

What people use it for

What Enlicitide does in the body

A ring-shaped (macrocyclic) peptide built to survive digestion. It blocks PCSK9, a protein that destroys the liver's LDL receptors, so the liver keeps more receptors and clears more LDL cholesterol from the blood.

Strength of evidence

Strong: Phase 3 trials lowered LDL cholesterol by about 60%.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

FDA-approved as Lipfendra, a once-daily tablet. Prescription only.

How it's taken

Route: Tablet by mouth, once daily

How long it lasts (half-life): Supports once-daily dosing

Latest research & news

Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.

Keep track of Enlicitide privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Enlicitide in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Heart & blood